Reports
Sale
Europe Aortic Stent Graft Market Size, Growth, Analysis: By Product: Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Demand Indicators, Others; Supplier Landscape; 2024-2032
Europe Aortic Stent Graft Market Outlook
The global aortic stent graft market size was valued at USD 3.1 billion in 2023, with Europe holding a significant market share. It is driven by the continuous advancements in stent graft material and design. The global market is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.
Key Takeaways
- The prevalence of abdominal aortic aneurysms (AAAs) is reported to fall in a range between 4% to 7.2% in Western populations. The high prevalence rate of aortic aneurysms is likely to boost demand for minimally invasive treatment options such as aortic stent grafts in coming years.
- Positive clinical outcomes indicate stent graft systems as an effective intervention, influencing the adoption rate and fuelling the Europe aortic stent graft market demand. In April 2023, Medtronic plc revealed positive results from its 10-year post-market ENGAGE registry for its Endurant stent graft system in treating patients with abdominal aortic aneurysms.
- The market is witnessing increased screening initiatives by the government that lead to high detection and diagnosis rates of aortic aneurysms, augmenting the demand for effective medical interventions including aortic stent grafts. One such abdominal aortic aneurysm screening program is available for men aged 65 or more in England.
Europe Aortic Stent Graft Market Analysis
An aortic stent graft is primarily utilized to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs). The stent graft is a tube that consists of a fabric supported by a metal mesh. It can help to seal the artery above and below the aneurysm (a weak spot in an artery) and prevent its rupture. The continuous innovation in stent graft materials and design has improved its flexibility and durability. Such advancements also contribute significantly to the Europe aortic stent graft market growth as they enable reduced procedural complications and better patient outcomes.
In Europe, the rising geriatric population coupled with the increased prevalence of risk factors such as smoking and hypertension, is leading to a high prevalence rate of aortic aneurysms. Recent data suggests that the prevalence of abdominal aortic aneurysms (AAAs) falls in a range between 4% to 7.2% in Western populations. With the increasing patient population having such aneurysms, the demand for minimally invasive treatment options, such as aortic stent grafts is likely to rise, which is expected to positively influence the Europe aortic stent graft market share in the forecast period.
In April 2023, Medtronic plc, revealed positive results from its 10-year post-market ENGAGE registry at the 2023 Charing Cross Symposium in London. The results were shared for its Endurant stent graft system in treating patients with abdominal aortic aneurysm. The study involving about 400 patients from 49 sites in 21 countries showed 94.7% freedom from aneurysm-related mortality and 64.1% decreased sac diameter at 10 years. Such real-world data establishes positive clinical outcomes, fuelling the adoption rates of aortic stent grafts and consequently driving market demand.
One of the major Europe aortic stent graft market trends is the increased screening initiatives by the government that lead to high detection and diagnosis rates of aortic aneurysms. Such government-sponsored screening programs not only heighten public awareness surrounding aneurysms but also augment the demand for effective treatments including aortic stent grafts. In England, one such abdominal aortic aneurysm screening program is available for men aged 65 or more, as they have the highest risk of having the condition. The improved access to screening services is poised to propel market growth in the region.
Europe Aortic Stent Graft Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts |
| End User | Hospitals, Ambulatory Surgical Centers, Others |
| Country | United Kingdom, Germany, France, Italy, Others |
Europe Aortic Stent Graft Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Medical, Inc.
- W.L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, Inc.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- CryoLife Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Aortic Stent Graft Market Overview
3.1 Europe Aortic Stent Graft Market Historical Value (2017-2023)
3.2 Europe Aortic Stent Graft Market Forecast Value (2024-2032)
4 Europe Aortic Stent Graft Market Landscape*
4.1 Europe Aortic Stent Graft: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Aortic Stent Graft: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Application
5 Europe Aortic Stent Graft Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Aortic Stent Graft Market Segmentation (2017-2032)
6.1 Europe Aortic Stent Graft Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Abdominal Aortic Stent Grafts
6.1.3 Thoracic Aortic Stent Grafts
6.2 Europe Aortic Stent Graft Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Europe Aortic Stent Graft Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 United Kingdom
6.3.3 Germany
6.3.4 France
6.3.5 Italy
6.3.6 Others
7 United Kingdom Aortic Stent Graft Market (2017-2032)
7.1 United Kingdom of Aortic Stent Graft Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Abdominal Aortic Stent Grafts
7.1.3 Thoracic Aortic stent Grafts
7.2 United Kingdom of Aortic Stent Graft Market (2017-2032) by End User
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.2.4 Others
8 Germany Aortic Stent Graft Market (2017-2032)
8.1 Germany Aortic Stent Graft Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Abdominal Aortic Stent Grafts
8.1.3 Thoracic Aortic stent Grafts
8.2 Germany Aortic Stent Graft Market (2017-2032) by End User
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Ambulatory Surgical Centers
8.2.4 Others
9 France Aortic Stent Graft Market (2017-2032)
9.1 France Aortic Stent Graft Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Abdominal Aortic Stent Grafts
9.1.3 Thoracic Aortic stent Grafts
9.2 France Aortic Stent Graft Market (2017-2032) by End User
9.2.1 Market Overview
9.2.2 Hospitals
9.2.3 Ambulatory Surgical Centers
9.2.4 Others
10 Italy Aortic Stent Graft Market (2017-2032)
10.1 Italy Aortic Stent Graft Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Abdominal Aortic Stent Grafts
10.1.3 Thoracic Aortic stent Grafts
10.2 Italy Aortic Stent Graft Market (2017-2032) by End User
10.2.1 Market Overview
10.2.2 Hospitals
10.2.3 Ambulatory Surgical Centers
10.2.4 Others
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Cook Medical, Inc.
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 W.l. Gore & Associates
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 MicroPort Scientific Corporation Inc.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Medtronic Plc.
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Lombard Medical, Inc.
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Endologix, INC.
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Terumo Corporation Inc.
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Cardinal Health Inc.
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Becton, Dickinson and Company
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Cryolife Inc.
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Europe Aortic Stent Graft – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Europe aortic stent graft market is expected to be driven by the rising demand for the global aortic stent graft market, which is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.2 billion by 2032.
The growing prevalence of aortic aneurysm and the heightened public awareness are fuelling the demand for the market.
One of the significant trends in the market is the increased number of clinical studies to evaluate aortic stent graft efficacy and safety profile. In April 2023, Medtronic plc revealed positive results from its 10-year post-market ENGAGE registry for its Endurant stent graft system in treating patients with abdominal aortic aneurysms.
Based on the product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts.
End users of the market are hospitals, and ambulatory surgical centers, among others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, Inc., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, and CryoLife Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER